Article Dans Une Revue Cell Death and Differentiation Année : 2021

Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients

François Ghiringhelli

Résumé

Ileal epithelial cell apoptosis and the local microbiota modulate the effects of oxaliplatin against proximal colon cancer by modulating tumor immunosurveillance. Here, we identified an ileal immune profile associated with the prognosis of colon cancer and responses to chemotherapy. The whole immune ileal transcriptome was upregulated in poor-prognosis patients with proximal colon cancer, while the colonic immunity of healthy and neoplastic areas was downregulated (except for the Th17 fingerprint) in such patients. Similar observations were made across experimental models of implanted and spontaneous murine colon cancer, showing a relationship between carcinogenesis and ileal inflammation. Conversely, oxaliplatin-based chemotherapy could restore a favorable, attenuated ileal immune fingerprint in responders. These results suggest that chemotherapy inversely shapes the immune profile of the ileum–tumor axis, influencing clinical outcome.

Fichier principal
Vignette du fichier
s41418-020-00684-w.pdf (4.15 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

hal-03682003 , version 1 (14-06-2022)

Licence

Identifiants

Citer

Marion Picard, Satoru Yonekura, Karolina Slowicka, Ioanna Petta, Conrad Rauber, et al.. Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients. Cell Death and Differentiation, 2021, 28 (5), pp.1532-1547. ⟨10.1038/s41418-020-00684-w⟩. ⟨hal-03682003⟩
229 Consultations
308 Téléchargements

Altmetric

Partager

  • More